We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics

84 hedge funds and large institutions have $61.1M invested in Aldeyra Therapeutics in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more call options, than puts

Call options by funds: $454K | Put options by funds: $100K

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

47% more capital invested

Capital invested by funds: $41.4M → $61.1M (+$19.7M)

17% more funds holding

Funds holding: 7284 (+12)

7.38% less ownership

Funds ownership: 56.55%49.17% (-7.4%)

27% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 26

Holders
84
Holders Change
+12
Holders Change %
+16.67%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
30
Increased
19
Reduced
26
Closed
18
Calls
$454K
Puts
$100K
Net Calls
+$354K
Net Calls Change
+$366K
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
51
State Street
Massachusetts
$80K -$1.4M -383,909 -95%
Ameriprise
52
Ameriprise
Minnesota
$76K +$67.4K +18,453 New
Connor, Clark & Lunn Investment Management (CC&L)
53
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$68K -$305K -83,376 -84%
PPA
54
Parametric Portfolio Associates
Washington
$68K -$7.75K -2,121 -11%
Bank of New York Mellon
55
Bank of New York Mellon
New York
$65K -$187K -51,246 -77%
CIBC World Market
56
CIBC World Market
Ontario, Canada
$63K +$54.8K +15,000 New
ECM
57
ExodusPoint Capital Management
New York
$55K +$47.8K +13,085 New
SW
58
SlateStone Wealth
Florida
$50K
BFM
59
Boothbay Fund Management
New York
$50K +$2.1K +575 +5%
Bank of America
60
Bank of America
North Carolina
$49K +$3.91K +1,070 +10%
Ohio Public Employees Retirement System (OPERS)
61
Ohio Public Employees Retirement System (OPERS)
Ohio
$49K +$42.5K +11,647 New
William Blair & Company
62
William Blair & Company
Illinois
$45K +$39.6K +10,850 New
LP
63
LMR Partners
United Kingdom
$44K +$38.5K +10,540 New
Group One Trading
64
Group One Trading
Illinois
$41K +$9.66K +2,645 +37%
Barclays
65
Barclays
United Kingdom
$27K -$4.27K -1,170 -15%
Citigroup
66
Citigroup
New York
$25K -$19.4K -5,300 -46%
FDCDDQ
67
Federation des caisses Desjardins du Quebec
Quebec, Canada
$24.4K +$21.4K +5,850 New
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
$17K +$3.33K +911 +28%
JP Morgan Chase
69
JP Morgan Chase
New York
$14K -$219K -59,911 -95%
UBS Group
70
UBS Group
Switzerland
$14K -$43.6K -11,936 -79%
PCM
71
Prelude Capital Management
New York
$14K +$12.5K +3,413 New
Bank of Montreal
72
Bank of Montreal
Ontario, Canada
$13K +$9.23K +2,527 New
TRCT
73
Tower Research Capital (TRC)
New York
$10K +$8.89K +2,434 New
PAG
74
Private Advisor Group
New Jersey
$5K +$4.06K +1,112 New
Simplex Trading
75
Simplex Trading
Illinois
$4K -$12.3K -3,366 -74%

ALDX Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2020, worth a combined $61.1M — up 47% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ALDX positions and 18 closed out — a net gain of 12 holders — while 19 added to existing stakes and 26 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.65M. The largest seller was BlackRock, cutting an estimated $4.13M.

  • 84 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2020, up from 72 in Q1 2020.
  • Funds reported $61.1M of Aldeyra Therapeutics stock for Q2 2020, up 47% quarter-over-quarter.
  • 30 funds opened new Aldeyra Therapeutics positions in Q2 2020 and 18 closed out, a net change of +12 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2020 was Ghost Tree Capital, an estimated $3.65M added.
  • The largest Aldeyra Therapeutics seller in Q2 2020 was BlackRock, an estimated $4.13M sold.

Based on aggregated 13F filings for Q2 2020.